PCV68 COST-EFFECTIVENESS OF RAISING HDL-CWITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH PERSISTENT DYSLIPIDEMIA IN AUSTRIAN, SWEDISH AND NORWEGIAN SETTINGS
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67479-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67479-7/fulltext
Title :
PCV68 COST-EFFECTIVENESS OF RAISING HDL-CWITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH PERSISTENT DYSLIPIDEMIA IN AUSTRIAN, SWEDISH AND NORWEGIAN SETTINGS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67479-7&doi=10.1016/S1098-3015(10)67479-7
First page :
Section Title :
Open access? :
No
Section Order :
43